Rakuten Medical: Series FDevelops and commercializes Alluminox platform-based photoimmunotherapy for cancer treatmentOct 4, 2026RoundOSRakuten MedicalCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesNorth AmericaSeries C+